Dwi Guna Laksana Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Dwi Guna Laksana Tbk. trades at Rp224 (market cap 2.05T, 224.5K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Dwi Guna Laksana Tbk. is far larger — about 12.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Dwi Guna Laksana Tbk. is more actively traded (224.5K versus 71K). Which is the better fit depends on your goals.
| DWGL | OBAT | |
|---|---|---|
Market Cap | 2.05T | 167.37B |
Volume | 224.5K | 71K |
Lot | 2.25K | 710 |
Turnover | 50.49M | 17.51M |
Average Price | 224.91 | 246.63 |
Value | 50.49M | 17.51M |
Indicative Equilibrium Price | 224 | 246 |
Indicative Equilibrium Volume | 1 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Dwi Guna Laksana Tbk (the Company) was established based on Notarial Deed No. 4 dated November 10, 1986 of Cornelia Juanda Tanuraharja, SH., a public notary in Surakarta.
Read more on DWGL →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →